ATP2B1 Rekombinanter Antikörper

ATP2B1 Rekombinant Antikörper für WB, IHC, Cytometric bead array, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC, Cytometric bead array, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

240848D10

Kat-Nr. : 83827-3-PBS

Synonyme

240848D10, PMCA1, PMCA1kb



Geprüfte Anwendungen

Produktinformation

83827-3-PBS bindet in WB, IHC, Cytometric bead array, Indirect ELISA ATP2B1 und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen ATP2B1 fusion protein Ag32423
Vollständiger Name ATPase, Ca++ transporting, plasma membrane 1
Berechnetes Molekulargewicht135 kDa
Beobachtetes Molekulargewicht130 kDa
GenBank-ZugangsnummerNM_001001323.1
Gene symbol ATP2B1
Gene ID (NCBI) 490
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

ATPase plasma membrane Ca2+ transporting 1 (ATP2B1, also known as plasma membrane Ca2+ pump isoform 1; PMCA1) belongs to the family of ATP-driven calmodulin-dependent Ca2+ pumps that participate in the regulation of intracellular free Ca2+ (PMID:35358416). The ATP2B1 contents of extracellular vesicles are increased in prostate cancer treated with enzalutamide and are negatively regulated by androgen receptors (PMID:29105980). ATP2B1 plays an important role in the prognosis of cholangiocarcinoma. Furthermore, ATP2B1 plays an important role in the prognosis of cholangiocarcinoma and can be a prognostic factor for cholangiocarcinoma (PMID:35875160).